Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer

David Mangelsdorf and colleagues show that nuclear receptor expression is strongly associated with clinical outcomes of lung cancer patients, and this expression profile is a potential prognostic signature for lung cancer patient survival time, particularly for individuals with early stage disease.

[1]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[2]  J. Manson,et al.  Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial , 2009, The Lancet.

[3]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[4]  Keitaro Matsuo,et al.  Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. Ferrando,et al.  NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia , 2009, Leukemia.

[6]  J. Siegfried,et al.  Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer. , 2009, Lung cancer.

[7]  V. Jordan,et al.  A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention. , 2009, Cancer research.

[8]  A. Bookout,et al.  Expression profiling of nuclear receptors in human and mouse embryonic stem cells. , 2009, Molecular endocrinology.

[9]  Igor Jurisica,et al.  Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.

[10]  Yang Xie,et al.  Predicting the future for people with lung cancer , 2008, Nature Medicine.

[11]  D. Moore,et al.  Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation , 2008, Hepatology.

[12]  Hueng-Sik Choi,et al.  Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner. , 2008, Endocrine journal.

[13]  S. Wacholder,et al.  Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival , 2008, PloS one.

[14]  B. Djavan,et al.  Androgen deprivation therapy. , 2008, Reviews in urology.

[15]  K. Coombes,et al.  Microarrays: retracing steps , 2007, Nature Medicine.

[16]  John D Minna,et al.  New molecularly targeted therapies for lung cancer. , 2007, The Journal of clinical investigation.

[17]  Lenore K. Beitel,et al.  Underexpression of Mineralocorticoid Receptor in Colorectal Carcinomas and Association with VEGFR-2 Overexpression , 2007, Journal of Gastrointestinal Surgery.

[18]  J. Milbrandt,et al.  Abrogation of nuclear receptors Nr4a3 andNr4a1 leads to development of acute myeloid leukemia , 2007, Nature Medicine.

[19]  B. Spiegelman,et al.  Synergy between PPARγ Ligands and Platinum-Based Drugs in Cancer , 2007 .

[20]  Jeremy J. W. Chen,et al.  A five-gene signature and clinical outcome in non-small-cell lung cancer. , 2007, The New England journal of medicine.

[21]  B. Spiegelman,et al.  Synergy between PPARgamma ligands and platinum-based drugs in cancer. , 2007, Cancer cell.

[22]  Zhifu Sun,et al.  A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer , 2006, PLoS medicine.

[23]  R. Evans,et al.  Anatomical Profiling of Nuclear Receptor Expression Reveals a Hierarchical Transcriptional Network , 2006, Cell.

[24]  Weimin He,et al.  Nuclear Receptor Expression Links the Circadian Clock to Metabolism , 2006, Cell.

[25]  S. Mukherjee,et al.  A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. , 2006, The New England journal of medicine.

[26]  Yi Zhang,et al.  Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. , 2006, Cancer research.

[27]  J. Siegfried.  Hormone replacement therapy and decreased lung cancer survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  PhD Facs Katsuyoshi Hatakeyama MD,et al.  Prognostic Groups in Colorectal Carcinoma Patients Based on Tumor Cell Proliferation and Classification and Regression Tree (CART) Survival Analysis , 2006, Annals of Surgical Oncology.

[29]  Robert A Hegele,et al.  Retinoid X receptor heterodimers in the metabolic syndrome. , 2005, The New England journal of medicine.

[30]  R. Evans,et al.  A Nuclear Receptor Atlas: macrophage activation. , 2005, Molecular endocrinology.

[31]  Mingui Fu,et al.  A Nuclear Receptor Atlas: 3T3-L1 adipogenesis. , 2005, Molecular endocrinology.

[32]  Takashi Suzuki,et al.  Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy. , 2005, Cancer research.

[33]  Yi-Ching Hsieh,et al.  Improved detection of prostate cancer using classification and regression tree analysis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  J. Siegfried,et al.  Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. , 2005, Cancer research.

[35]  Robert Gentleman,et al.  Reproducible Research: A Bioinformatics Case Study , 2005, Statistical applications in genetics and molecular biology.

[36]  E. Messing,et al.  Androgen deprivation therapy for prostate cancer: Current status and future prospects , 2004, The Prostate.

[37]  M. Cowles.  Modelling Survival Data in Medical Research (2nd ed.) (Book) , 2004 .

[38]  Y. Yatabe,et al.  Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  D. Robinson,et al.  Modelling survival data in medical research, second edition , 2004 .

[40]  James A Koziol,et al.  Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[42]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[43]  J. Luketich,et al.  Human Non-Small Cell Lung Tumors and Cells Derived from Normal Lung Express Both Estrogen Receptor α and β and Show Biological Responses to Estrogen , 2002 .

[44]  J. V. Von Roenn,et al.  Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma , 2002, AIDS.

[45]  M. Matsuda,et al.  Small Heterodimer Partner, an Orphan Nuclear Receptor, Augments Peroxisome Proliferator-activated Receptor γ Transactivation* , 2002, The Journal of Biological Chemistry.

[46]  J. Luketich,et al.  Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. , 2002, Cancer research.

[47]  R. Evans,et al.  Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.

[48]  A. Maitra,et al.  Microdissection and the study of cancer pathways. , 2001, Current molecular medicine.

[49]  T. A. Kerr,et al.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.

[50]  L. Moore,et al.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.

[51]  K R Hess,et al.  Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[54]  Leslie Lamport,et al.  Latex : A Document Preparation System , 1985 .

[55]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .